Cetuximab-targeted doxorubicin/MDR1 siRNA-loaded nanoparticles inhibited MCF-7/ADR cells’ proliferation through promotion of apoptosis and superior tumour inhibition vs. doxorubicin alone. This evidence concerns the gene ABCB1 and neoplasm.